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Pattern of Lymph Node Metastasis Correlates with Tumor Location 
in Bladder Cancer
Won Kyu Park, Young Sig Kim
Department of Urology, National Health Insurance Corporation Ilsan Hospital, Goyang, Korea 
Purpose: Resection of a large number of lymph nodes (LNs) increases survival in pa-
tients with LN-positive disease; however, morbidity also increases. Here, we inves-
tigated the correlation between tumor location and LN metastasis in bladder cancer.
Materials and Methods: Thirty-six patients with pathological N1 or higher bladder can-
cer, who underwent radical cystectomy with extended lymphadenectomy, were re-
viewed retrospectively. The tumor location was classified as right, left, front, posterior, 
or whole bladder. The LN metastasis pattern was classified as right, left, or bilateral. 
The correlation between tumor location and LN metastasis was determined by 
chi-square test. Survival rates were compared by Kaplan-Meier analysis.
Results: The numbers of patients with a tumor on the right (group 1), left (group 2), 
posterior (group 3), or whole (group 4) bladder were 16 (44.4%), 16 (44.4%), 2 (5.6%), 
and 2 (5.6%), respectively. In group 1, 14 patients (87.5%) had right-sided ipsilateral 
LNs, and 2 patients (12.5%) had left-sided contralateral LNs. In group 2, 4 patients 
(25%) had right-sided contralateral LNs, and 12 patients (75%) had left-sided ipsi-
lateral LNs. In group 3, both patients (100%) had right-sided posterior LNs. In group 
4, both patients (100%) had positive LNs on both sides. Tumor location and LN meta-
stasis were significantly correlated (p＜0.05). Moreover, the survival rate was sig-
nificantly higher in patients with no LN metastasis than in patients with ipsilateral 
or contralateral LN-positive bladder cancer.
Conclusions: The location of the bladder tumor and direction of metastatic spread were 
significantly correlated. Mandatory bilateral lymphadenectomy during radical cys-
tectomy should be questioned.
Key Words: Lymph node excision; Neoplasm metastasis; Urinary bladder neoplasms
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial 
License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, 
distribution, and reproduction in any medium, provided the original work is properly cited.
Article History:
received 16 August, 2011
accepted 4 October, 2011
Corresponding Author:
Young Sig Kim
Department of Urology, National Health 
Insurance Corporation Ilsan Hospital, 
1232, Baekseok-dong, Ilsandong- 
gu, Goyang 410-719, Korea
TEL: +82-31-900-0249
FAX: +82-31-900-0343
E-mail: urokim@nhimc.or.kr
INTRODUCTION
The pathological stage of primary bladder tumor and the 
presence of lymph node (LN) metastasis are the most im-
portant determinants of survival in patients with bladder 
cancer undergoing radical cystectomy (RC). A properly per-
formed lymphadenectomy helps detect occult nodal meta-
stases in 25% of the patients undergoing RC [1].
Currently, extended radical lymphadenectomy is stro-
ngly recommended for all patients undergoing RC for the 
treatment of bladder cancer, because of more accurate stag-
ing and improved postoperative survival [2]. Moreover, re-
cent reports have shown that the resection of a large num-
ber of LNs is associated with a survival advantage among 
patients with LN-positive disease. However, morbidity in-
creases if large numbers of LNs are resected [3].
Most bladder cancer patients who are required to under-
go RC are evaluated before the procedure by cystoscopy and 
computed tomography. Establishing a correlation between 
tumor location and the direction of LN metastatic spread 
is useful knowledge for surgeons performing RC with 
lymphadenectomy. The aim of this study was to determine 
the number and location of the tumors in the bladder and 
to determine the correlation between these factors and LN Korean J Urol 2012;53:14-17
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TABLE 1. Demographic characteristics of the patients
Characteristic Value
No. of patients
Age (yr)
Gender 
Male
Female
Pathologic T stage 
pT1
pT2
pT3
pT4
Pathologic N stage 
pN1
pN2
Pathology 
Grade 1
Grade 2
Grade 3
Mean dissected LNs
Mean positive LNs
36
66 (48-79)
30 (80)
  6 (20)
  3 (8.3)
15 (41.7)
11 (30.60)
  7 (19.40)
28 (77.8)
  8 (22.2)
  2 (5.5)
22 (61.1)
12 (33.4)
10.4 (4-29)
  1.8 (1-11)
Values are presented as mean (range) or number (%). 
LNs, lymph nodes.
TABLE 2. Tumor location and direction of metastatic spread in 
patients with LN-positive disease
Tumor location
LN positive direction
Right Left Bilateral 
Right
Left
Anterior
Posterior
Whole bladder
 14 (87.5)
4 (25)
0
  2 (100)
0
     2 (12.5)
12 (75)
0
0
0
0
0
0
0
2 (100)
Values are presented as mean (range) or number (%). 
LN, lymph node.
metastasis.
MATERIALS AND METHODS
1. Data collection
We retrospectively reviewed the records of patients who 
underwent surgery for bladder cancer (pathological N1 or 
higher) at Ilsan Hospital (Department of Urology, National 
Health Insurance Corporation Ilsan Hospital, Goyang, 
Korea) between 1 January 2000 and 31 August 2010. To en-
sure consistency, the same investigator reviewed all of the 
charts to extract data on demographics, admission and op-
eration, and pathological conditions.
2. Patients
A total of 78 cases of patients who had undergone RC with 
extended lymphadenectomy were identified from the 
database. We excluded 42 patients without LN metastasis 
or any other organ metastasis (M1).
3. Study definitions
The location of the cancer within the bladder was classified 
as right or left (defined by a vertical line between the ureter-
al orifices), front or posterior (defined by a horizontal cross 
line between the ureteral orifices), or whole (defined as the 
presence of an invading mass in more than two zones) 
bladder. Additionally, the LN metastasis pattern was clas-
sified as right, left, or bilateral in reference to the aorta.
4. Statistical analyses
Statistical analyses were performed by using SPSS ver. 
12.0 (SPSS Inc., Chicago, IL, USA). Continuous variables 
were expressed as medians (ranges) and were compared by 
using an independent t-test. Correlations between the lo-
cation of the bladder tumor and the site of LN metastasis 
were determined by using the chi-square test. A p value 
＜0.05 was considered significant. Survival was compared 
by using the log-rank test and Kaplan-Meier analysis.
RESULTS
The patients included 30 men and 6 women with an average 
age of 66 years (range, 48 to 79 years). There were 3 (8.3%), 
15 (41.7%), 11 (30.6%), and 7 (19.4%) pathologic pT1, pT2, 
pT3, and pT4 cases, respectively. The mean number of re-
sected LNs was 10.4 (range, 4 to 29), and the mean number 
of pathologically positive LNs was 1.8 (range, 1 to 11). As 
shown in Table 1, we observed 28 and 8 patients with patho-
logic pN1 and pN2, respectively. We observed 16 patients 
(44.4%) with bladder cancer on the right side (group 1), 16 
patients (44.4%) with bladder cancer on the left side (group 
2), 2 patients (5.6%) with posterior bladder cancer (group 
3), and 2 patients (5.6%) with whole bladder cancer (group 
4). In group 1, 14 patients (87.5%) had right-sided ipsi-
lateral positive LNs, and 2 patients (12.5%) had left-sided 
contralateral positive LNs (12.5%). In group 2, 4 patients 
(25%) had right-sided contralateral positive LNs, and 12 
patients (75%) had left-sided ipsilateral positive LNs. In 
group 3, two patients (100%) had right-sided posterior pos-
itive LNs. In group 4, two patients (100%) had positive LNs 
on both sides (Table 2). We found a significant correlation 
between the location of the tumor and the site of LN meta-
stasis (chi-square test, p＜0.001).
Ipsilateral metastasis was found in 26 cases, con-
tralateral metastasis in 6 cases, and no LN metastasis in 
42 cases. Kaplan-Meier survival analysis showed that the 
5 year median survival rate of patients with ipsilateral 
metastasis was 37%, with contralateral metastasis was 
18%, and without LN metastasis was 61% (p＜0.001) (Fig. 
1). Hence, the presence of ipsilateral or contralateral meta-
stasis predicts poor survival in patients with bladder 
cancer.Korean J Urol 2012;53:14-17
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FIG. 1. Kaplan-Meier analysis of survival rates.
DISCUSSION
Most bladder cancer patients experience lymphatic meta-
stasis in the course of disease progression. Nonetheless, 
many studies have shown that patients with LN-positive 
disease can achieve long-term survival by extended radical 
lymphadenectomies despite initial poor prognosis. Those 
same studies have shown that a positive LN status is found 
in 23% of all bladder cancer patients. Furthermore, data 
from those analyses highlight that patients with LN-pos-
itive disease have a mean 5 year recurrence-free survival 
rate of 30% (range, 20.9 to 35%) [1].
The relationship between the location of the primary tu-
mor and the direction of metastatic spread has not been 
fully investigated. Interestingly, however, a recent study 
has suggested a close correlation between the histologic 
characteristics of the primary tumor and the metastatic 
pattern [4]. To the best of our knowledge, this was the first 
study to analyze the correlation between tumor location in 
the bladder and pattern of LN metastasis relative to surviv-
al rates. Our data indicated a 5 year recurrence-free surviv-
al rate of 31%. The 5 year survival rate of the ipsilateral 
LN-positive group was 37%, whereas that of the con-
tralateral LN-positive group was 18%. This result in-
dicates that patients with contralateral LN metastasis 
might have a poorer prognosis than those with ipsilateral 
LN metastasis.
Of the 32 patients with a lateralized bladder tumor, 6 
(19%) had LNs in the contralateral side. This finding is in 
contrast with the findings of others. These data suggest 
that bilateral nodal dissection in patients with invasive 
bladder cancer does not necessarily occur. In fact, invasive 
bladder cancer usually spreads around the circumference 
of the bladder in a large percentage of cases. On the other 
hand, Wishnow et al. [5] analyzed patients in whom the pri-
mary bladder tumor was localized clearly to one side of the 
bladder, and they observed unsuspected metastasis only 
in patients with ipsilateral LN cancer. On the basis of these 
findings, we advocate a restricted pelvic lymphadenec-
tomy for patients in whom gross examination shows no evi-
dence of nodal metastasis during RC [6].
In our study, we found a significant correlation between 
the location of the bladder tumor and LN positivity. 
However, we are reluctant to not infer that there is no evi-
dence of nodal metastasis on the contralateral side in pa-
tients with bladder cancer [3]. In fact, our data indicate that 
lymphadenectomies must be performed bilaterally, even if 
the primary cancer is limited to the right or left hemisphere 
of the bladder wall, because even contralateral nodal meta-
stases may eventually occur. The risk of contralateral 
metastases is only slightly lower than that of ipsilateral 
metastases. In agreement with our claim, previous retro-
spective studies have shown a survival benefit for patients 
undergoing bilateral extended radical lymphadenec-
tomies [6-8].
Notwithstanding the possible advantages, all of the par-
ticipating urological surgeons unanimously agreed that an 
extended radical lymphadenectomy takes up to 60 minutes 
longer than does a lymphadenectomy that cranially ends 
at the level of the iliac arteries and is associated with in-
creased morbidity [3]. Therefore, knowledge of the exact lo-
cation of the tumor would be useful for surgeons performing 
RCs and lymphadenectomies. 
Although the group with LN metastasis on the con-
tralateral side had a poorer prognosis than did those with 
LN metastasis on the ipsilateral side, tumor grade was also 
a valid prognostic factor. When the latter is taken into ac-
count, the distance of the LN from the tumor itself may not 
be an independent prognostic factor.
The current study had some limitations: the surgeon 
may have been biased toward the presence of ipsilateral LN 
metastases, the sample population was small, a single op-
erator was not used, and a single chemotherapy protocol 
was not performed. 
CONCLUSIONS
The site of LN metastasis was significantly correlated with 
the location of the bladder tumor. Moreover, survival was 
significantly affected in patients with ipsilateral and con-
tralateral LN-positive bladder cancer.
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